Foamix Pharmaceuticals Ltd. Marketable Securities, Restricted, Current (Deprecated 2018-01-31)
Foamix Pharmaceuticals Ltd. had Marketable Securities, Restricted, Current (Deprecated 2018-01-31) of $290.00 thousand as of 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Notes › Investments
us-gaap:MarketableSecuritiesRestrictedCurrent · last filed 2018-03-01
- 2017-12-31: Marketable Securities, Restricted, Current (Deprecated 2018-01-31) $290.00K.
- 2017-06-30: Marketable Securities, Restricted, Current (Deprecated 2018-01-31) $287.00K.
- 2016-12-31: Marketable Securities, Restricted, Current (Deprecated 2018-01-31) $261.00K.
- 2016-06-30: Marketable Securities, Restricted, Current (Deprecated 2018-01-31) $954.00K.
| Period end | Marketable Securities, Restricted, Current (Deprecated 2018-01-31) |
|---|---|
| 2017-12-31 | $290.00K 10-K · filed 2018-03-01 |
| 2017-06-30 | $287.00K 6-K · filed 2017-08-08 |
| 2016-12-31 | $261.00K 10-K · filed 2018-03-01 |
| 2016-06-30 | $954.00K 6-K · filed 2016-08-10 |
| 2015-12-31 | $769.00K 20-F · filed 2017-02-21 |
| 2014-12-31 | $104.00K 20-F · filed 2015-03-17 |